Small Molecules Targeting SHP2
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
216
NCT03807219
The Study of Efficacy and Safety of a 60-day Use of the Magnox Comfort Compared to the Placebo in Subjects With NLC
Phase: N/A
Role: Lead Sponsor
Start: Feb 9, 2018
Completion: Aug 27, 2018
Loading map...